Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Jun;62(6):513–518. doi: 10.1136/ard.62.6.513

UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte

R Neame 1, A Carr 1, K Muir 1, M Doherty 1
PMCID: PMC1754579  PMID: 12759286

Abstract

Objectives: (1) To estimate the prevalence of chondrocalcinosis (CC) in the community and to characterise its compartmental distribution within the knee. (2) To investigate the associations between CC and individual radiographic features of osteoarthritis (OA) at the tibiofemoral joint (TFJ) and patellofemoral joint (PFJ).

Methods: From three community questionnaire studies investigating the prevalence of knee pain, standing anteroposterior and skyline radiographs were obtained on 1727 subjects (1084 women, 643 men; mean age 63.7; 999 (58%) with knee pain). A single observer recorded the presence and site of CC and graded osteophyte and joint space narrowing (JSN) using a line atlas. "OA" was globally defined as the presence of definite osteophyte and definite JSN. Minimum joint space width (JSW) was measured to 0.1 mm with a metred dial caliper

Results: (1) The crude prevalence of CC was 7.0% (95% confidence interval (CI) 5.8 to 8.2). This showed a strong association with age. The age adjusted odds ratio (aOR) for CC in women v men was 0.79 (95% CI 0.52 to 1.12). The age, sex, and knee pain standardised estimate for those aged >40 in Nottingham, UK was 4.5%. Patellofemoral CC was seen in only nine cases, all with tibiofemoral CC. (2) The age-sex aOR for the association between CC and OA was 2.08 at the PFJ (1.38 to 3.12) and 2.00 (1.11 to 3.60) at the TFJ. There was no association between measured JSW and CC at either the PFJ or TFJ. Both total osteophyte score and total number of sites with osteophyte were positively associated with CC; aOR for the upper quartile was 2.40 (1.48 to 3.90) and 1.94 (1.15 to 3.26), respectively. An association between CC and diuretic use was also demonstrated (aOR=2.07, 1.02 to 4.19).

Conclusions: In this large UK community study the age, sex, and knee pain adjusted prevalence of CC was 4.5%. There was a strong age association, but no sex predisposition. Patellofemoral CC was uncommon. An association between OA and CC was confirmed, but this appears to operate through an association with osteophyte rather than JSN. The new association between CC and diuretic use might theoretically be explained by diuretic induced hypomagnesaemia.

Full Text

The Full Text of this article is available as a PDF (121.0 KB).

Figure 1.

Figure 1

Open in a new tab

Prevalence of chondrocalcinosis by age and sex.

Figure 2.

Figure 2

Open in a new tab

Pain adjusted prevalence of chondrocalcinosis by age and sex.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agus Z. S., Wasserstein A., Goldfarb S. Disorders of calcium and magnesium homeostasis. Am J Med. 1982 Mar;72(3):473–488. doi: 10.1016/0002-9343(82)90519-8. [DOI] [PubMed] [Google Scholar]
  2. BOCHER J., MANKIN H. J., BERK R. N., RODNAN G. P. PREVALENCE OF CALCIFIED MENISCAL CARTILAGE IN ELDERLY PERSONS. N Engl J Med. 1965 May 27;272:1093–1097. doi: 10.1056/NEJM196505272722103. [DOI] [PubMed] [Google Scholar]
  3. Bennett R. M., Lehr J. R., McCarty D. J. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. J Clin Invest. 1975 Dec;56(6):1571–1579. doi: 10.1172/JCI108239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bland J. M., Altman D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307–310. [PubMed] [Google Scholar]
  5. Concoff A. L., Kalunian K. C. What is the relation between crystals and osteoarthritis? Curr Opin Rheumatol. 1999 Sep;11(5):436–440. doi: 10.1097/00002281-199909000-00019. [DOI] [PubMed] [Google Scholar]
  6. Dieppe P. A., Alexander G. J., Jones H. E., Doherty M., Scott D. G., Manhire A., Watt I. Pyrophosphate arthropathy: a clinical and radiological study of 105 cases. Ann Rheum Dis. 1982 Aug;41(4):371–376. doi: 10.1136/ard.41.4.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Doherty M., Chuck A., Hosking D., Hamilton E. Inorganic pyrophosphate in metabolic diseases predisposing to calcium pyrophosphate dihydrate crystal deposition. Arthritis Rheum. 1991 Oct;34(10):1297–1303. doi: 10.1002/art.1780341014. [DOI] [PubMed] [Google Scholar]
  8. Doherty M., Dieppe P. Crystal deposition disease in the elderly. Clin Rheum Dis. 1986 Apr;12(1):97–116. [PubMed] [Google Scholar]
  9. Doherty M., Dieppe P., Watt I. Low incidence of calcium pyrophosphate dihydrate crystal deposition in rheumatoid arthritis, with modification of radiographic features in coexistent disease. Arthritis Rheum. 1984 Sep;27(9):1002–1009. doi: 10.1002/art.1780270906. [DOI] [PubMed] [Google Scholar]
  10. Doherty M., Dieppe P., Watt I. Pyrophosphate arthropathy: a prospective study. Br J Rheumatol. 1993 Mar;32(3):189–196. doi: 10.1093/rheumatology/32.3.189. [DOI] [PubMed] [Google Scholar]
  11. Doherty M., Hamilton E., Henderson J., Misra H., Dixey J. Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families. Br J Rheumatol. 1991 Feb;30(1):10–15. doi: 10.1093/rheumatology/30.1.10. [DOI] [PubMed] [Google Scholar]
  12. Dyckner T., Wester P. O. Intracellular magnesium loss after diuretic administration. Drugs. 1984 Oct;28 (Suppl 1):161–166. doi: 10.2165/00003495-198400281-00016. [DOI] [PubMed] [Google Scholar]
  13. Felson D. T., Anderson J. J., Naimark A., Kannel W., Meenan R. F. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol. 1989 Sep;16(9):1241–1245. [PubMed] [Google Scholar]
  14. Genant H. K. Roentgenographic aspects of calcium pyrophosphate dihydrate crystal deposition disease (pseudogout). Arthritis Rheum. 1976 May-Jun;19 (Suppl 3):307–328. doi: 10.1002/1529-0131(197605/06)19:3+<307::aid-art1780190705>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  15. Graff R. D., Lazarowski E. R., Banes A. J., Lee G. M. ATP release by mechanically loaded porcine chondrons in pellet culture. Arthritis Rheum. 2000 Jul;43(7):1571–1579. doi: 10.1002/1529-0131(200007)43:7<1571::AID-ANR22>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  16. Halverson P. B., McCarty D. J. Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann Rheum Dis. 1986 Jul;45(7):603–605. doi: 10.1136/ard.45.7.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hamilton E., Pattrick M., Hornby J., Derrick G., Doherty M. Synovial fluid calcium pyrophosphate dihydrate crystals and alizarin red positivity: analysis of 3000 samples. Br J Rheumatol. 1990 Apr;29(2):101–104. doi: 10.1093/rheumatology/29.2.101. [DOI] [PubMed] [Google Scholar]
  18. Harris J., Carter A. R., Glick E. N., Storey G. O. Ankylosing hyperostosis. I. Clinical and radiological features. Ann Rheum Dis. 1974 May;33(3):210–215. doi: 10.1136/ard.33.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ho A. M., Johnson M. D., Kingsley D. M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000 Jul 14;289(5477):265–270. doi: 10.1126/science.289.5477.265. [DOI] [PubMed] [Google Scholar]
  20. Johnson K., Hashimoto S., Lotz M., Pritzker K., Goding J., Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum. 2001 May;44(5):1071–1081. doi: 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  21. Johnson K., Moffa A., Chen Y., Pritzker K., Goding J., Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res. 1999 Jun;14(6):883–892. doi: 10.1359/jbmr.1999.14.6.883. [DOI] [PubMed] [Google Scholar]
  22. Jones A. C., Chuck A. J., Arie E. A., Green D. J., Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 1992 Dec;22(3):188–202. doi: 10.1016/0049-0172(92)90019-a. [DOI] [PubMed] [Google Scholar]
  23. Laurin C. A., Dussault R., Levesque H. P. The tangential x-ray investigation of the patellofemoral joint: x-ray technique, diagnostic criteria and their interpretation. Clin Orthop Relat Res. 1979 Oct;(144):16–26. [PubMed] [Google Scholar]
  24. Mazzuca S. A., Brandt K. D., Dieppe P. A., Doherty M., Katz B. P., Lane K. A. Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of osteoarthritis in the standing anteroposterior knee radiograph. Arthritis Rheum. 2001 Aug;44(8):1786–1794. doi: 10.1002/1529-0131(200108)44:8<1786::AID-ART315>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  25. Nagaosa Y., Mateus M., Hassan B., Lanyon P., Doherty M. Development of a logically devised line drawing atlas for grading of knee osteoarthritis. Ann Rheum Dis. 2000 Aug;59(8):587–595. doi: 10.1136/ard.59.8.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. O'Reilly S. C., Muir K. R., Doherty M. Screening for pain in knee osteoarthritis: which question? Ann Rheum Dis. 1996 Dec;55(12):931–933. doi: 10.1136/ard.55.12.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Okazaki T., Saito T., Mitomo T., Siota Y. Pseudogout: clinical observations and chemical analyses of deposits. Arthritis Rheum. 1976 May-Jun;19 (Suppl 3):293–305. doi: 10.1002/1529-0131(197605/06)19:3+<293::aid-art1780190704>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  28. Pattrick M., Hamilton E., Wilson R., Austin S., Doherty M. Association of radiographic changes of osteoarthritis, symptoms, and synovial fluid particles in 300 knees. Ann Rheum Dis. 1993 Feb;52(2):97–103. doi: 10.1136/ard.52.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rachow J. W., Ryan L. M. Inorganic pyrophosphate metabolism in arthritis. Rheum Dis Clin North Am. 1988 Aug;14(2):289–302. [PubMed] [Google Scholar]
  30. Resnick D., Niwayama G., Goergen T. G., Utsinger P. D., Shapiro R. F., Haselwood D. H., Wiesner K. B. Clinical, radiographic and pathologic abnormalities in calcium pyrophosphate dihydrate deposition disease (CPPD): pseudogout. Radiology. 1977 Jan;122(1):1–15. doi: 10.1148/122.1.1. [DOI] [PubMed] [Google Scholar]
  31. Rosenthal A. K., McCarty B. A., Cheung H. S., Ryan L. M. A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues. Arthritis Rheum. 1993 Apr;36(4):539–542. doi: 10.1002/art.1780360415. [DOI] [PubMed] [Google Scholar]
  32. Sanmarti R., Kanterewicz E., Pladevall M., Pañella D., Tarradellas J. B., Gomez J. M. Analysis of the association between chondrocalcinosis and osteoarthritis: a community based study. Ann Rheum Dis. 1996 Jan;55(1):30–33. doi: 10.1136/ard.55.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sanmartí R., Pañella D., Brancós M. A., Canela J., Collado A., Brugués J. Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia. Ann Rheum Dis. 1993 Jun;52(6):418–422. doi: 10.1136/ard.52.6.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Summers M. N., Haley W. E., Reveille J. D., Alarcón G. S. Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis Rheum. 1988 Feb;31(2):204–209. doi: 10.1002/art.1780310208. [DOI] [PubMed] [Google Scholar]
  35. Wilkins E., Dieppe P., Maddison P., Evison G. Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis. 1983 Jun;42(3):280–284. doi: 10.1136/ard.42.3.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. ZITNAN D., SIT'AJ S. Chondrocalcinosis articularis Section L Clinical and radiological study. Ann Rheum Dis. 1963 May;22:142–152. doi: 10.1136/ard.22.3.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. van Beuningen H. M., van der Kraan P. M., Arntz O. J., van den Berg W. B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest. 1994 Aug;71(2):279–290. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES